The global antacids market is growing moderately and has significant growth potential attributed to growing gastrointestinal disorders as antacid is used to neutralize stomach acidity and relieve indigestion and heartburn. It has been on the market for several years now. Changing dietary habits and extremely oily junk foods consumption, have been the driving factors for the antacid market growth. Hyperacidity is considered as a highly prevalent problem among all ages. It mainly results from consumption of alcohol, high acidic foods, cigarette`s along with issues such as obesity, aging, and stress.
To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/antacid-market
According to International Foundation for Gastrointestinal Disorders (IFGD), in 2017, the occurrence of Gastroesophageal Reflux Disease (GERD) was more than 20% in North America, 23% in Latin America, 15% in Europe, 5% in East Asia, and more than 30% in the Middle East. This high prevalence of GERD has created demand for antacids across the globe.
Browse for Full Report Description@ https://www.omrglobal.com/industry-reports/antacid-market
The prevalence of GERD is observed in individuals aged over 60 years. The group of individuals aging over 60 years is rising at a significant rate. In elderly population, the acidic complication occurs irregularly, which presents a threat of hyperacidity. Additionally, such individuals suffer from various symptomatic disorders including Barrett esophagus, esophageal cancer, and erosive esophagitis for which an array of therapies is utilized for treatment and the utilization of antacid increases, hence drives the growth of antacids industry.
Furthermore, multiple organizations such as FGD and International Foundation for Functional Gastrointestinal Disorders (IFFGD), among more have encouraged the use of antacid for patients suffering from GERD. E-commerce has also provided significant growth to the antacid market through online retailing channels.
Some of the major players in the antacid market include Sun Pharmaceuticals, Ltd., AstraZeneca, PLC, Reckitt Benckiser Group PLC, Johnson & Johnson, Service, Inc., Procter & Gamble, Co., Takeda Pharmaceutical Company Ltd., and Bayer AG, among more. Various collaborations, product launches, mergers, and several strategic movements have been observed among these players. The competition is increasing significantly, and more innovations and strategic moves are expected in the years to come. For instance, in March 2016, Sun Pharma Global Consumer Healthcare business announced the digital launch of Pepmelt campaigns across various digital and social mediums. The launch was an important part of Sun Pharma’s strategy to leverage the media to increase awareness about its antacid product available all across India.
Current Market Trends Covered in the Report:
- Increasing Geriatric Population
- Increasing Prevalence of GERD and Heartburn
- Increasing Awareness about GERD
Global Antacids Market – Segmentation
Global Antacid Market by Drug Class
- H2 Antagonist
- Proton Pump Inhibitors
- Acid Neutralizers
Global Antacid Market by Formulation Type
- Tablet
- Liquid
- Powder
Global Antacids Market –Region
North America
- US
- Canada
Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- India
- Japan
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Abbott Laboratories
- AstraZeneca PLC
- Bayer AG
- Dabur India Ltd.
- Reddy’s Laboratories Ltd.
- First Aid Only, a company of Acme United Corp.
- GCP Laboratories
- GlaxoSmithKline PLC
- Guardian Drug Company
- Pfizer Inc.
(This release has been published on OMR Industry Journal. OMR Industry Journal is not responsible for any content included in this release.)
